{"mainPropery":{"diseaseId":10704,"diseaseName":"Pontocerebellar hypoplasia type 1","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/10704/pontocerebellar-hypoplasia-type-1","synonyms":["Pontocerebellar hypoplasia with infantile spinal muscular atrophy","Pontocerebellar hypoplasia with anterior horn cell disease"],"synonyms-with-source":[{"name":"Pontocerebellar hypoplasia with infantile spinal muscular atrophy"},{"name":"Pontocerebellar hypoplasia with anterior horn cell disease"}],"identifiers":[{"identifierType":"OMIM","identifierId":"607596"},{"identifierType":"ORPHANET","identifierId":"2254"},{"identifierType":"UMLS","identifierId":"C1843504"}]},"diseaseCategories":[{"diseaseTypeId":5,"diseaseTypeName":"Congenital and Genetic Diseases","source":"Orphanet"},{"diseaseTypeId":17,"diseaseTypeName":"Nervous System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":357,"resourceName":"Fetal Health Foundation","abbreviation":"","address1":"9786 S Holland Street","address2":"","address3":"","address4":"","address5":"","city":"Littleton","state":"CO","zip":"80127 ","country":"United States","phone":"303-932-0553 ","tty":"","tollFree":"877-789-4673","fax":"","email":" info@fetalhealthfoundation.org","url":"http://www.fetalhealthfoundation.org/","freeText":""},{"resourceID":3681,"resourceName":"The Joshua Deeth Foundation","abbreviation":"","address1":"38 James Square","address2":"Second Floor","address3":"Room 2","address4":"","address5":"","city":"Crieff","state":"","zip":"PH7 3EY","country":"Scotland","phone":"01764650949","tty":"","tollFree":"","fax":"","email":"","url":"http://www.thejoshuadeethfoundation.co.uk/","freeText":""}],"resource descriptions":[{"id":7,"resourceId":10,"resourceName":"Online Mendelian Inheritance in Man (OMIM)","descriptionText":"<a href='http://www.omim.org/607596' target='_blank'>Online Mendelian Inheritance in Man (OMIM)</a> is a catalog of human genes and genetic disorders. Each entry has a summary of related medical articles. It is meant for health care professionals and researchers. OMIM is maintained by Johns Hopkins University School of Medicine.&nbsp;<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=pontocerebellar%5BAll%20Fields%5D%20AND%20%28%22abnormalities%22%5BSubheading%5D%20OR%20%22abnormalities%22%5BAll%20Fields%5D%20OR%20%22hypoplasia%22%5BAll%20Fields%5D%29%20AND%20type%5BAll%20Fields%5D%20AND%201%5BAll%20Fields%5D&cmd=DetailsSearch' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Pontocerebellar hypoplasia type 1. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":10,"resourceId":13,"resourceName":"MedlinePlus Genetics","descriptionText":"<a href='http://ghr.nlm.nih.gov/condition=pontocerebellarhypoplasia' target='_blank'>Genetics Home Reference (GHR)</a> contains information on Pontocerebellar hypoplasia type 1. This website is maintained by the National Library of Medicine.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1457,"resourceId":2104,"resourceName":"Genetic Services","descriptionText":"To find a medical professional who specializes in genetics, you can ask your doctor for a referral or you can search for one yourself. Online directories are provided by the <a href='http://www.acmg.net/ACMG/Genetic_Services_Directory_Search.aspx' target='_blank'>American College of Medical Genetics</a> and the&nbsp;<a href='https://www.findageneticcounselor.com/' target='_blank'>National Society of Genetic Counselors</a>. If you need additional help, <a href=\"https://rarediseases.info.nih.gov/about-gard/contact-gard\">contact a GARD Information Specialist</a>. You can also&nbsp;<a href='https://ghr.nlm.nih.gov/primer#consult' target='_blank'>learn more about genetic consultations</a>&nbsp;from Genetics Home Reference.","resourceClassificationName":"Find a Specialist","resourceClassificationSectionName":"Healthcare Resources"},{"id":1526,"resourceId":2158,"resourceName":"Genetic Testing Registry","descriptionText":"The <a href='http://www.ncbi.nlm.nih.gov/gtr/conditions/C1843504' target='_blank'>Genetic Testing Registry</a> (GTR) provides information about the genetic tests for this condition. The intended audience for the GTR is health care providers and researchers. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.<br />\r\n","resourceClassificationName":"Diagnosis","resourceClassificationSectionName":"Testing Resources"},{"id":1527,"resourceId":2159,"resourceName":"National Organization for Rare Disorders","descriptionText":"The <a href='http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/1211/viewAbstract' target='_blank'>National Organization for Rare Disorders</a> (NORD) has a report for patients and families about this condition. NORD is a patient advocacy organization for individuals with rare diseases and the organizations that serve them.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2254' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/OMIM:607596' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"}],"overviewQuestion":{"questionId":3314,"questionText":"What is pontocerebellar hypoplasia type 1?","answerText":"<strong><strong>Pontocerebellar hypoplasia type 1 (PCH1) </strong></strong>is a genetic disease that affects the development of the brain. Babies and children with this disease have an unusually small and underdeveloped <a href=\"https://medlineplus.gov/ency/imagepages/18008.htm\">cerebellum</a>, which is the part of the brain that coordinates movement. A region of the brain called the <a href=\"https://medlineplus.gov/ency/imagepages/19236.htm\">pons</a> also fails to develop properly. The pons, which is located at the base of the brain in an area called the <a href=\"https://medlineplus.gov/ency/imagepages/18007.htm\">brainstem</a>, sends signals between the cerebellum and the rest of the brain.[2283] Individuals with PCH1 also experience a degeneration of the <a href=\"http://www.sciencedirect.com/topics/neuroscience/anterior-horn-of-spinal-cord\">anterior horn cells</a>, which are responsible for helping the <a href=\"https://www.merckmanuals.com/home/brain,-spinal-cord,-and-nerve-disorders/biology-of-the-nervous-system/spinal-cord\">spinal cord</a> send signals to the muscles. Problems with the anterior horn cells cause severe muscle weakness.[2284][5700] <br />\r\n<br />\r\nPCH1 is caused by <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a> to <a href=\"https://ghr.nlm.nih.gov/gene/EXOSC3\"><em>EXOSC3</em></a><em>, </em><a href=\"https://ghr.nlm.nih.gov/gene/TSEN54\"><em>TSEN54</em></a><em>, </em><a href=\"https://ghr.nlm.nih.gov/gene/RARS2\"><em>RARS2</em></a><em>, </em>and <a href=\"https://ghr.nlm.nih.gov/gene/VRK1\"><em>VRK1</em></a>.[5699] The disease is inherited in an <a href=\"https://ghr.nlm.nih.gov/primer/inheritance/inheritancepatterns\">autosomal recessive</a> manner.[2283] Diagnosis of PCH1 is based on brain imaging and tests to rule out other causes of problems with brain development.[2284] Treatment for PCH1 is aimed at relieving the symptoms of the disease. Most children with PCH1 pass away in infancy or early childhood.[2283][2284]<strong><br />\r\n<br />\r\n</strong>","dateModified":"2017-08-14T00:00:00"},"basicQuestions":[{"questionId":3316,"questionText":"What are the symptoms of pontocerebellar hypoplasia type 1?","answerText":"Pontocerebellar hypoplasia type 1 (PCH1) may first present in the prenatal period when mothers feel reduced movement of the baby (<a href=\"http://www.kickscount.org.uk/mums/your-babys-movements/what-is-reduced-fetal-movement/\">reduced fetal movement</a>). The presence of too much fluid surrounding the baby in the womb (<a href=\"https://medlineplus.gov/ency/article/003267.htm\">polyhydramnios</a>) may also be noted. In most cases, signs and symptoms of PCH1 can be observed in the newborn period, as babies may not be able to breathe properly (<a href=\"https://medlineplus.gov/respiratoryfailure.html\">respiratory insufficiency</a>) and may have muscle weakness (<a href=\"https://medlineplus.gov/ency/article/003298.htm\">hypotonia</a>). Babies may also be born with the inability to move joints (<a href=\"https://medlineplus.gov/ency/article/003185.htm\">joint contractures</a>).[2284] <br />\r\n<br />\r\nLater in the newborn period, other symptoms may become apparent including <a href=\"https://medlineplus.gov/visionimpairmentandblindness.html\">visual impairment</a>, uncontrolled movements of the eye (<a href=\"https://www.aoa.org/patients-and-public/eye-and-vision-problems/glossary-of-eye-and-vision-conditions/nystagmus?sso=y\">nystagmus</a>), and uncontrolled movements of the muscles (<a href=\"https://medlineplus.gov/ency/article/003198.htm\">ataxia</a>). Babies with PCH1 may struggle to feed at the breast or with a bottle because their swallowing muscles are weakened. After a few months, the baby may have a smaller than typical head size (<a href=\"https://www.cdc.gov/ncbddd/birthdefects/microcephaly.html\">microcephaly</a>).[5699] Affected babies also typically do not meet milestones such as being able to sit up, and they may have <a href=\"https://medlineplus.gov/ency/article/001523.htm\">intellectual disability</a>.[2283] <br />\r\n<br />\r\nIn some cases, babies affected by PCH1 may not show signs or symptoms of the disease until they are a few months old. In these cases, the baby may have a better long-term outlook than other affected individuals.[2284] Individuals who survive past infancy may develop <a href=\"https://medlineplus.gov/seizures.html\">seizures</a> as they get older.[5699]<br />","dateModified":"2017-08-14T00:00:00","resourceClassificationName":"Symptoms","references":[{"referenceId":2283,"authors":"","articleTitle":"Pontocerebellar hypoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/pontocerebellar-hypoplasia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2284,"authors":"Omar S and Ajibola A","articleTitle":"Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2012","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pontocerebellar-hypoplasia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5699,"authors":"Namavar Y, Barth PG, Poll-The BT, and Baas F","articleTitle":"Classification, diagnosis and potential mechanisms in Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2011","volume":"6(50)","pages":"","url":"https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-6-50","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3315,"questionText":"What causes pontocerebellar hypoplasia type 1?","answerText":"About half of all cases of pontocerebellar hypoplasia type 1 (PCH1) are caused by <a href=\"https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation\">mutations</a> (changes) in the&nbsp;<a href=\"https://ghr.nlm.nih.gov/gene/EXOSC3\"><em>EXOSC3</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a><em>. </em>Other genes that have been associated with PCH1 include <a href=\"https://ghr.nlm.nih.gov/gene/TSEN54\"><em>TSEN54</em></a><em>, </em><a href=\"https://ghr.nlm.nih.gov/gene/RARS2\"><em>RARS2</em></a><em>, </em>and <a href=\"https://ghr.nlm.nih.gov/gene/VRK1\"><em>VRK1</em></a><em>.</em>[2283] These genes are normally responsible for helping the body process <a href=\"https://www.news-medical.net/life-sciences/What-is-RNA.aspx\">RNA</a>, which is a form of genetic information similar to <a href=\"https://ghr.nlm.nih.gov/primer/basics/dna\">DNA</a>. When RNA cannot be processed properly, the body does not receive instructions about how it should work and develop. It is thought that the brain and muscles are particularly susceptible to changes in RNA processing. Therefore, when there are changes in any of the genes mentioned above, the body does not process RNA properly, causing the brain and muscles to not work properly.[2283]","dateModified":"2017-08-14T00:00:00","resourceClassificationName":"Cause","references":[{"referenceId":2283,"authors":"","articleTitle":"Pontocerebellar hypoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/pontocerebellar-hypoplasia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3317,"questionText":"How is pontocerebellar hypoplasia type 1 inherited?","answerText":"Pontocerebellar hypoplasia type 1 (PCH1) is inherited in an <a href=\"https://ghr.nlm.nih.gov/primer/inheritance/inheritancepatterns\">autosomal recessive</a> manner.[2283] This means that both copies of the <a href=\"https://ghr.nlm.nih.gov/gene/EXOSC3\"><em>EXOSC3</em></a><em>, </em><a href=\"https://ghr.nlm.nih.gov/gene/TSEN54\"><em>TSEN54</em></a><em>, </em><a href=\"https://ghr.nlm.nih.gov/gene/RARS2\"><em>RARS2</em></a><em>, </em>or<em> </em><a href=\"https://ghr.nlm.nih.gov/gene/VRK1\"><em>VRK1</em></a> <a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">genes</a> must be changed in order to have symptoms of the disease. We inherit one copy of each gene from our mother and the other from our father. <br />\r\n<br />\r\nPeople with a mutation in only one copy of a gene causing PCH1 are known as carriers. Carriers typically do not show signs and symptoms of the disease. When two carriers of PCH1 have children together, for each child there is a:<br />\r\n<ul style=\"list-style-type: disc;\">\r\n    <li>25% chance that the child will have PCH1</li>\r\n    <li>50% chance that the child will be a carrier of PCH1 like the parents</li>\r\n    <li>25% chance that the child will have two working copies of the gene, so the child will not have PCH1 and will not be a carrier.</li>\r\n</ul>","dateModified":"2017-08-14T00:00:00","resourceClassificationName":"Inheritance","references":[{"referenceId":2283,"authors":"","articleTitle":"Pontocerebellar hypoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/pontocerebellar-hypoplasia","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12109,"questionText":"How is pontocerebellar hypoplasia type 1 diagnosed?","answerText":"Pontocerebellar hypoplasia type 1 (PCH1) is typically diagnosed when healthcare professionals see signs and symptoms consistent with the disease. Tests that may be ordered include an <a href=\"https://medlineplus.gov/ency/article/003335.htm\">MRI</a> or <a href=\"https://medlineplus.gov/ctscans.html\">CT scan</a> of the brain to visualize the <a href=\"https://medlineplus.gov/ency/imagepages/18008.htm\">cerebellum</a> and the <a href=\"https://medlineplus.gov/ency/imagepages/19236.htm\">pons</a>. Other tests such as <a href=\"https://medlineplus.gov/metabolicpanel.html\">metabolic tests</a> may also be completed to rule out other causes of the symptoms.[2284] If PCH1 is the suspected cause of the symptoms, <a href=\"https://ghr.nlm.nih.gov/primer/testing/genetictesting\">genetic testing</a> may be done to confirm the diagnosis.[13701]<br />","dateModified":"2017-08-14T15:24:00","resourceClassificationName":"Diagnosis","references":[{"referenceId":2284,"authors":"Omar S and Ajibola A","articleTitle":"Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2012","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pontocerebellar-hypoplasia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13701,"authors":"Eggens VRC, Barth PG, and Baas F","articleTitle":"EXOSC3-Related Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"GeneReviews","date":"August 21, 2014","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK236968/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":3318,"questionText":"How might pontocerebellar hypoplasia type 1 be treated?","answerText":"Treatment for pontocerebellar hypoplasia type 1 (PCH1) is aimed at treating the signs and symptoms present in each individual. Management options may include <a href=\"http://www.wcpt.org/what-is-physical-therapy\">physical therapy</a> or braces on the limbs to help with <a href=\"https://medlineplus.gov/ency/article/003185.htm\">joint contractures</a>, <a href=\"https://www.nhlbi.nih.gov/health/health-topics/topics/vent\">ventilation machines</a> for breathing assistance, anti-seizure medication, and a <a href=\"http://www.healthline.com/health/feeding-tube-insertion-gastrostomy\">feeding tube</a> if the child is not able to eat without one.[5699] These treatment options are aimed at relieving some of the symptoms of PCH1, but there is no cure for the disease.[2284][13701]<br />","dateModified":"2017-08-14T00:00:00","resourceClassificationName":"Treatment","references":[{"referenceId":2284,"authors":"Omar S and Ajibola A","articleTitle":"Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2012","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pontocerebellar-hypoplasia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5699,"authors":"Namavar Y, Barth PG, Poll-The BT, and Baas F","articleTitle":"Classification, diagnosis and potential mechanisms in Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2011","volume":"6(50)","pages":"","url":"https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-6-50","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13701,"authors":"Eggens VRC, Barth PG, and Baas F","articleTitle":"EXOSC3-Related Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"GeneReviews","date":"August 21, 2014","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK236968/","authors2":"","placeOfPublication":"","publisher":""}]},{"questionId":12110,"questionText":"What is the long-term outlook for people affected by pontocerebellar hypoplasia type 1?","answerText":"Unfortunately, most children with pontocerebellar hypoplasia type 1 (PCH1) pass away within the first year of life. In some cases, affected individuals have survived later into childhood or into early adulthood. These individuals are most often those who did not show signs and symptoms right at birth, but instead developed symptoms during the first few months of life.[2284] Certain particular mutations within the <a href=\"https://ghr.nlm.nih.gov/gene/EXOSC3\"><em>EXOSC3</em></a><em> </em><a href=\"https://ghr.nlm.nih.gov/primer/basics/gene\">gene</a> may be associated with a better prognosis, including a longer estimated survival time.[13701][13702]<br />","dateModified":"2017-08-14T15:29:00","resourceClassificationName":"Prognosis","references":[{"referenceId":2284,"authors":"Omar S and Ajibola A","articleTitle":"Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2012","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pontocerebellar-hypoplasia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13701,"authors":"Eggens VRC, Barth PG, and Baas F","articleTitle":"EXOSC3-Related Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"GeneReviews","date":"August 21, 2014","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK236968/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13702,"authors":"Baas F","articleTitle":"Pontocerebellar hypoplasia type 1","bookWebsiteJournalTitle":"Orphanet","date":"July 2013","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2254","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[{"referenceId":2283,"authors":"","articleTitle":"Pontocerebellar hypoplasia","bookWebsiteJournalTitle":"Genetics Home Reference (GHR)","date":"November 2014","volume":"","pages":"","url":"https://ghr.nlm.nih.gov/condition/pontocerebellar-hypoplasia","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":2284,"authors":"Omar S and Ajibola A","articleTitle":"Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"National Organization for Rare Disorders (NORD)","date":"2012","volume":"","pages":"","url":"https://rarediseases.org/rare-diseases/pontocerebellar-hypoplasia/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5700,"authors":"","articleTitle":"Pontocerebellar Hypoplasia Type 1A; PCH1A","bookWebsiteJournalTitle":"Online Mendelian Inheritance in Man","date":"April 14, 2017","volume":"","pages":"","url":"http://omim.org/entry/607596","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5699,"authors":"Namavar Y, Barth PG, Poll-The BT, and Baas F","articleTitle":"Classification, diagnosis and potential mechanisms in Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"Orphanet J Rare Dis","date":"2011","volume":"6(50)","pages":"","url":"https://ojrd.biomedcentral.com/articles/10.1186/1750-1172-6-50","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13701,"authors":"Eggens VRC, Barth PG, and Baas F","articleTitle":"EXOSC3-Related Pontocerebellar Hypoplasia","bookWebsiteJournalTitle":"GeneReviews","date":"August 21, 2014","volume":"","pages":"","url":"https://www.ncbi.nlm.nih.gov/books/NBK236968/","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":13702,"authors":"Baas F","articleTitle":"Pontocerebellar hypoplasia type 1","bookWebsiteJournalTitle":"Orphanet","date":"July 2013","volume":"","pages":"","url":"http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=2254","authors2":"","placeOfPublication":"","publisher":""}],"relatedDiseases":[],"gardCases":[],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3895,"phenoTypeName":"Abnormal foot morphology","percentRanges":"-"},{"phenoTypeId":8720,"phenoTypeName":"Ataxia","percentRanges":"-"},{"phenoTypeId":4,"phenoTypeName":"Autosomal recessive inheritance","percentRanges":"-"},{"phenoTypeId":4475,"phenoTypeName":"Basal ganglia gliosis","percentRanges":"-"},{"phenoTypeId":9414,"phenoTypeName":"Cerebellar hypoplasia","percentRanges":"-"},{"phenoTypeId":7898,"phenoTypeName":"Congenital contracture","percentRanges":"-"},{"phenoTypeId":6258,"phenoTypeName":"Congenital onset","percentRanges":"-"},{"phenoTypeId":5173,"phenoTypeName":"Degeneration of anterior horn cells","percentRanges":"-"},{"phenoTypeId":13565,"phenoTypeName":"EMG: neuropathic changes","percentRanges":"-"},{"phenoTypeId":5156,"phenoTypeName":"Fasciculations","percentRanges":"-"},{"phenoTypeId":3410,"phenoTypeName":"Feeding difficulties in infancy","percentRanges":"-"},{"phenoTypeId":9384,"phenoTypeName":"Generalized hypotonia","percentRanges":"-"},{"phenoTypeId":8723,"phenoTypeName":"Global developmental delay","percentRanges":"-"},{"phenoTypeId":10649,"phenoTypeName":"Hyperreflexia","percentRanges":"-"},{"phenoTypeId":2717,"phenoTypeName":"Hypoplasia of the pons","percentRanges":"-"},{"phenoTypeId":12152,"phenoTypeName":"Hypoplasia of the ventral pons","percentRanges":"-"},{"phenoTypeId":8715,"phenoTypeName":"Intellectual disability","percentRanges":"-"},{"phenoTypeId":9419,"phenoTypeName":"Muscle weakness","percentRanges":"-"},{"phenoTypeId":8716,"phenoTypeName":"Muscular hypotonia","percentRanges":"-"},{"phenoTypeId":1132,"phenoTypeName":"Neuronal loss in basal ganglia","percentRanges":"-"},{"phenoTypeId":5255,"phenoTypeName":"Progressive","percentRanges":"-"},{"phenoTypeId":3822,"phenoTypeName":"Psychomotor retardation","percentRanges":"-"},{"phenoTypeId":13725,"phenoTypeName":"Respiratory insufficiency","percentRanges":"-"},{"phenoTypeId":13640,"phenoTypeName":"Spinal muscular atrophy","percentRanges":"-"}],"medicalProducts":[],"EncodedName":"Pontocerebellar_hypoplasia_type_1"}